CausalSentinel

Protein Dossier — IL6R (Interleukin-6 receptor subunit alpha)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Rheumatoid arthritis -0.0748 0.0124 1.49e-09 Wald ratio 1 cis NA
Coronary heart disease -0.0442 0.00853 2.21e-07 Wald ratio 1 cis NA
Eczema 0.0674 0.0153 1.08e-05 Wald ratio 1 cis NA
Crohn’s disease -0.0473 0.0114 3.18e-05 Wald ratio 1 cis NA
Iron 0.0357 0.00897 6.89e-05 Wald ratio 1 cis NA
Myocardial infarction -0.0377 0.00955 8.01e-05 Wald ratio 1 cis NA
Non-cancer illness code self-reported: asthma 0.022 0.006 2.44e-04 Wald ratio 1 cis NA
Inflammatory bowel disease -0.0332 0.0094 4.11e-04 Wald ratio 1 cis NA
Diagnoses - main ICD10: K80 Cholelithiasis 0.0491 0.0145 7.15e-04 Wald ratio 1 cis NA
Diagnoses - main ICD10: M54 Dorsalgia 0.0541 0.0161 7.80e-04 Wald ratio 1 cis NA
Diagnoses - main ICD10: L03 Cellulitis 0.0751 0.0226 8.88e-04 Wald ratio 1 cis NA
Transferrin Saturation 0.03 0.00915 0.00106 Wald ratio 1 cis NA
…and 121 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-4139_71_2 IL-6 sRa Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

311 association rows across 163 traits (282 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Interleukin-6 receptor subunit alpha levels 4e-5877 rs12126142 12 GCST90012025 no MR -> candidate analysis
Interleukin-6 receptor subunit alpha levels (IL6R.4139.71.2) 7e-1101 rs4129267 5 GCST90241647 no MR -> candidate analysis
Blood protein levels 8e-450 rs2228145 4 GCST006585 no MR -> candidate analysis
C-reactive protein levels 3e-436 rs61812598 26 GCST009777 no MR -> candidate analysis
Circulating IL6 levels (id: OID00390_OID21276) 6e-380 rs61812598 1 GCST90859752 no MR -> candidate analysis
Circulating IL6 levels (id: OID00482_OID21276) 2e-364 rs61812598 1 GCST90859842 no MR -> candidate analysis
CSF1/IL6 protein level ratio 3e-352 rs61812598 1 GCST90314285 no MR -> candidate analysis
Interleukin-6 receptor subunit alpha (analyte X4139.71) leve 1e-346 rs2228145 1 GCST90425952 no MR -> candidate analysis
Circulating IL6 levels (id: OID00666_OID21276) 4e-323 rs61812598 1 GCST90860010 no MR -> candidate analysis
Circulating IL6 levels (id: OID00947_OID21276) 3e-319 rs61812598 1 GCST90860179 no MR -> candidate analysis
Cerebrospinal fluid protein IL6R levels 7e-316 rs4129267 1 GCST90945011 no MR -> candidate analysis
C-reactive protein 9e-315 rs12730935 4 GCST90018950 no MR -> candidate analysis
…and 151 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1042 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
rheumatoid arthritis 0.824 common-variant locus MR: beta=-0.0748, p=1.49e-09 (cis)
Eczematoid dermatitis 0.862 established (curated) no MR -> candidate analysis
COVID-19 0.435 common-variant locus no MR -> candidate analysis
juvenile idiopathic arthritis 0.128 common-variant locus MR: beta=-0.128, p=0.0105 (cis)
coronary artery disorder 0.907 common-variant locus no MR -> candidate analysis
hyper-IgE recurrent infection syndrome 5, autosomal recessive 0.663 established (curated) no MR -> candidate analysis
asthma 0.882 common-variant locus MR: beta=0.022, p=2.44e-04 (cis)
atopic eczema 0.903 common-variant locus no MR -> candidate analysis
dermatitis 0.823 common-variant locus no MR -> candidate analysis
abdominal aortic aneurysm 0.867 common-variant locus no MR -> candidate analysis
ankylosing spondylitis 0.724 common-variant locus MR: beta=-0.103, p=0.0257 (cis)
allergic rhinitis 0.833 common-variant locus no MR -> candidate analysis
myocardial infarction 0.779 common-variant locus MR: beta=-0.0377, p=8.01e-05 (cis)
coronary atherosclerosis 0.79 common-variant locus no MR -> candidate analysis
gout 0.773 common-variant locus MR: beta=0.0383, p=0.0304 (cis)

Of the 15 rows above, 9 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 4 known modulators (Interleukin-6 receptor subunit alpha)
gnomAD constraint pLI=7.9e-11, LOEUF=1.03 — LoF-tolerant
GWAS Catalog 149 unique SNPs / 368 rows
ClinVar 366 records; 1 pathogenic in sample of 30
PharmGKB/ClinPGx 3 clinical annotations across 1 drugs

Caveats declared by the tools

Sources

Provenance